Yoon JH - Search Results

1

Quantitative promoter hypermethylation profiles of ductal carcinoma in situ in North American and Korean women: Potential applications for diagnosis.

Lee JS, Fackler MJ, Teo WW, Lee JH, Choi C, Park MH, Yoon JH, Zhang Z, Argani P, Sukumar S. Lee JS, et al. Among authors: yoon jh. Cancer Biol Ther. 2008 Sep;7(9):1398-406. doi: 10.4161/cbt.7.9.6425. Epub 2008 Sep 4. Cancer Biol Ther. 2008. PMID: 18769130 Free article.

2

Basal-like breast cancer displays distinct patterns of promoter methylation.

Lee JS, Fackler MJ, Lee JH, Choi C, Park MH, Yoon JH, Zhang Z, Sukumar S. Lee JS, et al. Among authors: yoon jh. Cancer Biol Ther. 2010 Jun 15;9(12):1017-24. doi: 10.4161/cbt.9.12.11804. Epub 2010 Jun 18. Cancer Biol Ther. 2010. PMID: 20505321 Free PMC article.

3

Detection of Slit2 promoter hypermethylation in tissue and serum samples from breast cancer patients.

Kim GE, Lee KH, Choi YD, Lee JS, Lee JH, Nam JH, Choi C, Park MH, Yoon JH. Kim GE, et al. Among authors: yoon jh. Virchows Arch. 2011 Oct;459(4):383-90. doi: 10.1007/s00428-011-1143-5. Epub 2011 Sep 6. Virchows Arch. 2011. PMID: 21894562

4

Reduced MUC4 expression is a late event in breast carcinogenesis and is correlated with increased infiltration of immune cells as well as promoter hypermethylation in invasive breast carcinoma.

Cho JS, Park MH, Lee JS, Yoon JH. Cho JS, et al. Among authors: yoon jh. Appl Immunohistochem Mol Morphol. 2015 Jan;23(1):44-53. doi: 10.1097/PAI.0000000000000041. Appl Immunohistochem Mol Morphol. 2015. PMID: 24992172

5

Evaluation of promoter hypermethylation detection in serum as a diagnostic tool for breast carcinoma in Korean women.

Kim JH, Shin MH, Kweon SS, Park MH, Yoon JH, Lee JS, Choi C, Fackler MJ, Sukumar S. Kim JH, et al. Among authors: yoon jh. Gynecol Oncol. 2010 Aug 1;118(2):176-81. doi: 10.1016/j.ygyno.2010.04.016. Epub 2010 May 13. Gynecol Oncol. 2010. PMID: 20466412

6

Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer.

Kim GE, Lee JS, Choi YD, Lee KH, Lee JH, Nam JH, Choi C, Kim SS, Park MH, Yoon JH, Kweon SS. Kim GE, et al. Among authors: yoon jh. BMC Cancer. 2014 Dec 16;14:959. doi: 10.1186/1471-2407-14-959. BMC Cancer. 2014. PMID: 25510449 Free PMC article.

7

Reduced RKIP Expression is Associated With Breast Neoplastic Progression and is Correlated With Poor Outcomes and Aberrant Methylation in Breast Carcinoma.

Kim GE, Kim NI, Lee JS, Park MH, Yoon JH. Kim GE, et al. Among authors: yoon jh. Appl Immunohistochem Mol Morphol. 2017 Aug;25(7):467-474. doi: 10.1097/PAI.0000000000000323. Appl Immunohistochem Mol Morphol. 2017. PMID: 26894644 Clinical Trial.

8

Borderline and malignant phyllodes tumors display similar promoter methylation profiles.

Kim JH, Choi YD, Lee JS, Lee JH, Nam JH, Choi C, Park MH, Yoon JH. Kim JH, et al. Among authors: yoon jh. Virchows Arch. 2009 Dec;455(6):469-75. doi: 10.1007/s00428-009-0858-z. Epub 2009 Nov 19. Virchows Arch. 2009. PMID: 19924440

9

Stromal matrix metalloproteinase-14 expression correlates with the grade and biological behavior of mammary phyllodes tumors.

Kim GE, Kim JH, Lee KH, Choi YD, Lee JS, Lee JH, Nam JH, Choi C, Park MH, Yoon JH. Kim GE, et al. Among authors: yoon jh. Appl Immunohistochem Mol Morphol. 2012 May;20(3):298-303. doi: 10.1097/PAI.0b013e318235a132. Appl Immunohistochem Mol Morphol. 2012. PMID: 22505012

10

Hormone receptors expression in phyllodes tumors of the breast.

Kim YH, Kim GE, Lee JS, Lee JH, Nam JH, Choi C, Park MH, Yoon JH. Kim YH, et al. Among authors: yoon jh. Anal Quant Cytol Histol. 2012 Feb;34(1):41-8. Anal Quant Cytol Histol. 2012. PMID: 22590818

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,353 results

Search Page

Filters